SABS logo

SAB Biotherapeutics, Inc.

SABS
Healthcare|Biotechnology|US
$3.03
+0.09 (+3.06%)
DCF Value
$0.04
Tangible Book / Share
$2.26
Cash / Share
$1.12
Next Earnings Report
Mar 8, 2027
EPS est. -$0.28 · Revenue est. $125.0K
Financing Filings (last 12 months)
5
Shelf registrations / offering prospectuses — latest Aug 21, 2026 (424B3). Possible dilution.

Upcoming Data Readouts (1)

Nov 2027
Est. completion
P2Type 1 Diabetes
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
NCT07187531n=159

Recent Press Releases

SAB BIO Reports Q3 2026 Financial Results and Provides Business Highlights
Nov 5, 2026 · GlobeNewsWire
SAB BIO to Host Third Quarter 2026 Financial Results Conference Call and Webcast on November 5, 2026, 08:30 AM ET
Oct 29, 2026 · GlobeNewsWire
SAB BIO to Participate in Chardan 10th Annual Healthcare Conference
Oct 14, 2026 · GlobeNewsWire
SAB BIO Receives FDA Fast Track Designation for SAB-142 in Stage 3 Type 1 Diabetes
Oct 13, 2026 · GlobeNewsWire
SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research Congress
Oct 1, 2026 · GlobeNewsWire
SAB BIO to Present SAB-142 Data at the 62nd Annual Meeting of the European Association for the Study of Diabetes
Sep 22, 2026 · GlobeNewsWire
SAB BIO to Participate in Upcoming Investor Conferences
Sep 1, 2026 · GlobeNewsWire

SEC Filings (65)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 202610-QQuarterly reportDocumentIndex
Oct 22, 202625-NSEDocumentIndex
Oct 13, 20268-KMaterial eventDocumentIndex
Aug 21, 2026424B3Offering prospectusDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 12, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 10, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 6, 202610-QQuarterly reportDocumentIndex
Jul 7, 20268-KMaterial eventDocumentIndex
Jun 18, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 12, 202610-QQuarterly reportDocumentIndex
May 4, 20268-KMaterial eventDocumentIndex
May 1, 2026SC 13GPassive 5%+ stakeDocumentIndex
Apr 30, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 22, 20268-KMaterial eventDocumentIndex
Mar 31, 2026S-8Employee stock planDocumentIndex
Mar 23, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Mar 19, 20268-KMaterial eventDocumentIndex
Mar 19, 2026424B5Offering prospectusDocumentIndex
Mar 17, 2026424B5Offering prospectusDocumentIndex
Mar 11, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Mar 10, 20268-KMaterial eventDocumentIndex
Mar 9, 202610-KAnnual reportDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 22, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 12, 20268-KMaterial eventDocumentIndex
Jan 7, 2026EFFECTDocumentIndex
Jan 7, 20268-KMaterial eventDocumentIndex
Dec 29, 2025S-3Shelf registrationDocumentIndex
Dec 29, 20258-KMaterial eventDocumentIndex
Dec 15, 2025S-8Employee stock planDocumentIndex